Search research articles
Contact Us
Filters
Showing results (451-460 of 683) with videos related to
Page
of 69
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2020
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma
Kathryn Lasseter, Amin H Nassar, Lana Hamieh, et al.
Journal of Women'S Health (2002)
|
February 18, 2016
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer
Chioma O Erondu, Anthony J Alberg, Elisa V Bandera, et al.
Molecular Carcinogenesis
|
April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk
Ellen L Goode, Kristin L White, Robert A Vierkant, et al.
Nature Genetics
|
April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
Xiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome
Andrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
A chromatin fiber model explains cell-free DNA fragmentation signatures of active regulatory elements
Alexis Yang, Garyoung Gary Lee, Surya Chhetri, et al.
Gynecologic Oncology
|
April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies
Stéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies
A M Hussein, W P Petros, M Ross, et al.
Cancer
|
April 16, 2026
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617
Margo B Gerke, Angelo Marra, Yuan Liu, et al.
Nature Reviews. Cancer
|
May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Page
of 69
Search research articles
Search
Showing results (451-460 of 683) with videos related to
Sort By:
Page
of 69
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2020
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma
Kathryn Lasseter, Amin H Nassar, Lana Hamieh, et al.
Journal of Women'S Health (2002)
|
February 18, 2016
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer
Chioma O Erondu, Anthony J Alberg, Elisa V Bandera, et al.
Molecular Carcinogenesis
|
April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk
Ellen L Goode, Kristin L White, Robert A Vierkant, et al.
Nature Genetics
|
April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
Xiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome
Andrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
A chromatin fiber model explains cell-free DNA fragmentation signatures of active regulatory elements
Alexis Yang, Garyoung Gary Lee, Surya Chhetri, et al.
Gynecologic Oncology
|
April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies
Stéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies
A M Hussein, W P Petros, M Ross, et al.
Cancer
|
April 16, 2026
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617
Margo B Gerke, Angelo Marra, Yuan Liu, et al.
Nature Reviews. Cancer
|
May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Page
of 69